Evidence map›Paper›PMID 24719417›Full record

ArticleJournal of virology2014

Kaposi's sarcoma-associated herpesvirus ORF45 mediates transcriptional activation of the HIV-1 long terminal repeat via RSK2.

John Karijolich, Yang Zhao, Bret Peterson, Qiang Zhou, Britt Glaunsinger

Abstract read
In one paragraph

Article in Journal of virology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed.

  1. Article
  2. Review
  3. A case of convergent evolution: Several viral and bacterial pathogens hijack RSK kinases through a common linear motif.Proceedings of the National Academy of Sciences of the United States of America · 2022
    Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

John KarijolichDepartment of Plant and Microbial Biology, University of California, Berkeley, California, USA.
Yang ZhaoDepartment of Cell and Molecular Biology, University of California, Berkeley, California, USA.
Bret PetersonDepartment of Plant and Microbial Biology, University of California, Berkeley, California, USA.
Qiang ZhouDepartment of Cell and Molecular Biology, University of California, Berkeley, California, USA.
Britt GlaunsingerDepartment of Plant and Microbial Biology, University of California, Berkeley, California, USA Department of Cell and Molecular Biology, University of California, Berkeley, California, USA glaunsinger@berkeley.edu.

Funding

REGULATION OF TRANSCRIPTIONAL ELONGATION BY HIV1 TATR01AI041757 · NIAID · UNIVERSITY OF CALIFORNIA BERKELEY · PI ZHOU, QIANG · 1997 to 2019
$6.6M
Tat cofactors and control of HIV-1 latencyR01AI095057 · NIAID · UNIVERSITY OF CALIFORNIA BERKELEY · PI ZHOU, QIANG · 2011 to 2015
$1.9M
NIAID NIH HHS R01 AI041757NIAID NIH HHS R01 AI095057NIAID NIH HHS R01AI095057NIAID NIH HHS R01AI41757
6 · The paper itself

Abstract

unlabelledRobust activation of human immunodeficiency virus type 1 (HIV-1) gene expression occurs upon superinfection with Kaposi's sarcoma-associated herpesvirus (KSHV), a common AIDS-associated pathogen. Though the mechanisms underlying this phenotype remain unknown, several KSHV-encoded factors have been reported to stimulate HIV-1 long terminal repeat (LTR) activity. Here, we systematically evaluated the ability of KSHV tegument proteins to modulate the activation of an integrated HIV-1 LTR and revealed that the most potent individual activator is ORF45. ORF45 directs an increase in RNA polymerase II recruitment to the HIV-1 LTR, leading to enhanced transcriptional output. ORF45 is a robust activator of the p90 ribosomal S6 kinases (RSK), and we found that this activity is necessary but not sufficient to increase transcription from the LTR. Of the three widely expressed RSK isoforms, RSK2 appears to be selectively involved in LTR stimulation by both KSHV ORF45 and HIV-1 Tat. However, constitutively active RSK2 is unable to stimulate the LTR, suggesting that ORF45 may preferentially direct this kinase to a specific set of targets. Collectively, our findings reveal a novel transcriptional activation function for KSHV ORF45 and highlight the importance of RSK2 in shaping the transcriptional environment during infection. IMPORTANCE: Kaposi's sarcoma-associated herpesvirus (KSHV) is a prominent AIDS-associated pathogen. Previous studies have shown that infection of cells containing human immunodeficiency virus type 1 (HIV-1) with KSHV leads to potent stimulation of HIV-1 gene expression by activating the HIV-1 promoter, termed the long terminal repeat (LTR). Here, we compared the abilities of various KSHV proteins to activate gene expression from the HIV-1 LTR and found that KSHV ORF45 is the most potent activator. ORF45 is known to induce cell signaling through ribosomal S6 kinase (RSK) and enhance protein translation. However, we revealed that the activation of a specific isoform of RSK by ORF45 also leads to increased mRNA synthesis from the LTR by the host RNA polymerase. Collectively, our findings provide new insight into the interviral interactions between KSHV and HIV that may ultimately impact disease.

Indexed as

HIV Long Terminal RepeatTranscriptional ActivationAnimalsCell LineCoinfectionHerpesviridae InfectionsHerpesvirus 8, HumanHIV-1HIV InfectionsHumansImmediate-Early ProteinsMiceRibosomal Protein S6 Kinases, 90-kDaImmediate-Early ProteinsORF45 protein, Kaposi's sarcoma-associated herpesvirusribosomal protein S6 kinase, 90kDa, polypeptide 3Ribosomal Protein S6 Kinases, 90-kDa

Identifiers

PMID24719417
PMCPMC4054375

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.